FOLLOW US

Mon

August 24, 2026

AbbVie Buys Celsius For $250M

America June 27, 2024

AbbVie Buys Celsius Therapeutics For $250M

Chicago-based pharmaceutical company AbbVie announced Thursday its acquisition of Celsius Therapeutics Inc., a privately held clinical-stage biotechnology firm focused on…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter